Johnson & Johnson’s latest proposal to settle thousands of complaints alleging that asbestos in previously marketed talc-containing products caused ovarian cancer would give individual plaintiffs a direct say on whether to accept it.
J&J executives are confident the proposal to pay plaintiffs making ovarian cancer claims a total of $6.48bn over 25 years will be accepted to resolve 99.75% of pending talc lawsuits against it and its US affiliates
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?